Jeito
Finance · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Rue Pillet Will, Paris, Ile-de-France,...Website
jeito.lifeRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Jeito
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients' access in Europe & the United States. Jeito Capital has EUR 534m under management. Jeito Capital is based in Paris with a presence in Europe and the United States.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jeito your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Jeito is spiking on competitors!
Funding: Get notified immidiatlly once Jeito has new funding data
Click to see if Jeito had a recent Job posting/layoffs
Earning: See what the market has to say on Jeito recently announced quarterly report
Product Launch: Get notified when Jeito launches new products
Jeito, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Jeito
Check if Jeito has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Jeito is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Jeito is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Jeito.
Jeito Tech Stack
A closer look at the technologies used by Jeito
Most Recent Scoops
Project
Spending/Investment
Event
Person-Based
Events, Clinical Operations, Podcast
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Jeito News & Media
Jeito Capital secures over $1.2bn for new biopharma investments
The fund’s resources allow it to invest up to €150m, helping businesses advance clinical development.Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
Paris, February 24, 2026 – Jeito Capital (“Jeito”), a leading global independent private equity fund dedicated to biopharma, announced today that it was the cornerstone investor in the second closing of the oversubscribed Series A financing of Alveus Therapeutics (“Alveus”), a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases. This closing brings the total amount raised in the Series A round to $1973 million. Jeito made a significant com
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Jeito
Sign Up For FreeTo access detailed company insights
Jeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the grow... Read More
